|
Peptide
|
Amino acid sequence
|
Anticancer Activity
|
Cancer Cell
|
|
D-peptide A
D-peptide B
D-peptide C
D-peptide D
|
RLYLRIGRR
RLRLRIGRR
ALYLAIRRR
RLLLRIGRR
|
Cell membrane disruption
|
Human cervix, glioma, lung, mouse myeloma, African green monkey kidney
|
|
D-K6L9
|
LKLLKKLLKK LLKLL
|
Necrosis via membrane depolarization
|
Human prostate
|
|
NRC-03
|
GRRKRKWLRR IGKGVKIIGG AALDHL
|
Cell membrane lysis
|
Human breast
|
|
NRC-07
|
RWGKWFKKAT HVGKHVGKAA LTAYL
|
Cell membrane lysis
|
Human breast
|
|
Gomesin
|
ZCRRLCYKQR CVTYCRGR
|
Unclear
|
Murine melanoma, human breast, colon and cervix adenocarcinoma
|
|
Hepcidin TH2-3
|
QSHLSLCRWC CNCCRSNKGC
|
Cell membrane lysis
|
Human cervix, hepatocellular carcinoma, fibrosarcoma
|
|
Dermaseptin B2
|
GLWSKIKEVG KEAAKAAAK AAGKAALGAV SEAV
|
Necrosis
|
Human prostate and breast
|
|
PTP7
|
FLGALFKALS KLL
|
Apoptosis induction
|
Human lung, breast and hepatocellular carcinoma
|
|
MGA2
|
GIGKFLHSAK KFGKAFVGEI MNSGGKKWKM RRNQF–WVKVQRG
|
Necrosis and apoptosis
|
Cervix and lung, melanoma, rat glioma
|
|
HNP-1
|
ACYCRIPACI AGERRYGTCI YQGRLWAFCC
|
Mediation of antitumor immunity
|
Mouse colon and brest
|
|
Tachyplesin
|
KWCFRVCYRG ICYRRCR
|
Activation of the classic complement pathway
|
Human prostate
|
|
Temporin-1CEa
|
FVDLKKIANI INSIF
|
Membrane disruption, calcium release, ROS production
|
Human breast
|
|
NK-2
|
KILRGVCKKI MRTFLRRISK DILTGKK
|
Necrotic death after peptide intercalation into phospholipid phosphatidylserine -containing membranes.
|
Human chronic myelogenous leukemia, histiocytic lymphoma, acute T cell leukemia, acute lymphoblastic leukemia, neuroblastoma, colorectal adenocarcinoma
|
|
Bovine lactoferricin B6 (LbcinB6)
|
RRWQWR
|
Apoptosis, disruption of mitochondrial membrane
|
Human acute lymphoblastic T leukemia, acute T cell leukemia
|
|
Cecropin CB1
|
KWKVFKKIEK MGRNIRNGIV KAGPKWKVFK KIEK
|
Unclear
|
Human acute lymphoblastic T leukemia, lung carcinoma, stomach carcinoma
|